These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35814503)

  • 1. Sofosbuvir in the Treatment of Hepatitis E virus Infection: A Review of
    Lampejo T
    J Clin Exp Hepatol; 2022; 12(4):1225-1237. PubMed ID: 35814503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A small animal model of chronic hepatitis E infection using immunocompromised rats.
    Sridhar S; Wu S; Situ J; Shun EH; Li Z; Zhang AJ; Hui K; Fong CH; Poon VK; Chew NF; Yip CC; Chan WM; Cai JP; Yuen KY
    JHEP Rep; 2022 Oct; 4(10):100546. PubMed ID: 36052220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infection.
    Gallacher J; Taha Y; da Silva Filipe A; Ijaz S; McPherson S
    IDCases; 2023; 32():e01741. PubMed ID: 36942308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.
    Sooryanarain H; Rogers AJ; Cao D; Haac MER; Karpe YA; Meng XJ
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of HBV, HCV, & HEV, with 12-week long use of tenofovir, sofosbuvir, daclatasvir, and ribavirin: A case report.
    Wahid B
    J Infect Public Health; 2020 Jan; 13(1):149-150. PubMed ID: 31235341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report.
    Fraga M; Gouttenoire J; Sahli R; Chtioui H; Marcu C; Pascual M; Moradpour D; Vionnet J
    BMC Gastroenterol; 2019 May; 19(1):76. PubMed ID: 31126238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective.
    Todesco E; Mazzola A; Akhavan S; Abravanel F; Poynard T; Roque-Afonso AM; Peytavin G; Marcelin AG; Calmus Y; Lecuyer L; Guillemain R; Conti F
    Antivir Ther; 2018; 23(5):463-465. PubMed ID: 29504509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Most Patients of Hepatitis C Virus Infection in India Present Late for Interferon-Based Antiviral Treatment: An Epidemiological Study of 777 Patients from a North Indian Tertiary Care Center.
    Gupta V; Kumar A; Sharma P; Bansal N; Singla V; Arora A
    J Clin Exp Hepatol; 2015 Jun; 5(2):134-41. PubMed ID: 26155041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.
    Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B
    Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122.
    Haldipur B; Bhukya PL; Arankalle V; Lole K
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
    Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
    Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment.
    Gömer A; Dinkelborg K; Klöhn M; Jagst M; Wißing MH; Frericks N; Nörenberg P; Behrendt P; Cornberg M; Wedemeyer H; Steinmann E; Maasoumy B; Todt D
    JHEP Rep; 2024 Mar; 6(3):100989. PubMed ID: 38434938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic hepatitis E: a review of the literature.
    Fujiwara S; Yokokawa Y; Morino K; Hayasaka K; Kawabata M; Shimizu T
    J Viral Hepat; 2014 Feb; 21(2):78-89. PubMed ID: 24383921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis E virus and Zoonosis: Recent Advances and Therapeutic Implications.
    Hon KLE; Leung AKC; Wong AHC; Sridhar S
    Recent Adv Inflamm Allergy Drug Discov; 2023; 17(1):54-63. PubMed ID: 36635905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and management strategies for chronic hepatitis E infection.
    Abravanel F; Lhomme S; Marion O; Péron JM; Kamar N; Izopet J
    Expert Rev Anti Infect Ther; 2023 Feb; 21(2):143-148. PubMed ID: 36625025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin.
    Dao Thi VL; Debing Y; Wu X; Rice CM; Neyts J; Moradpour D; Gouttenoire J
    Gastroenterology; 2016 Jan; 150(1):82-85.e4. PubMed ID: 26408347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients.
    Ollivier-Hourmand I; Lebedel L; Lecouf A; Allaire M; Nguyen TTN; Lier C; Dao T
    BMC Infect Dis; 2020 Jul; 20(1):522. PubMed ID: 32677900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis E virus: A potential threat for patients with liver disease and liver transplantation.
    van der Eijk AA; Pas SD; de Man RA
    Best Pract Res Clin Gastroenterol; 2017 Apr; 31(2):143-150. PubMed ID: 28624102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparity of basal and therapeutically activated interferon signalling in constraining hepatitis E virus infection.
    Zhou X; Xu L; Wang W; Watashi K; Wang Y; Sprengers D; de Ruiter PE; van der Laan LJ; Metselaar HJ; Kamar N; Peppelenbosch MP; Pan Q
    J Viral Hepat; 2016 Apr; 23(4):294-304. PubMed ID: 26620360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
    von Felden J; Alric L; Pischke S; Aitken C; Schlabe S; Spengler U; Giordani MT; Schnitzler P; Bettinger D; Thimme R; Xhaard A; Binder M; Ayuk F; Lohse AW; Cornelissen JJ; de Man RA; Mallet V
    J Hepatol; 2019 Sep; 71(3):465-472. PubMed ID: 31108159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.